CGT

1,163개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,163 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleZhongmou TherapeuticsPhase 2

high dose (ZM-02, ZM-02 (high dose))

Retinitis Pigmentosa (RP) · Retinitis Pigmentosa (RP)

#RetinitisPigmentosaRP#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 62Status Recruiting
CGTLimited DatastaleAstraZenecaPhase 2

Epidermal growth factor receptor (EGFRv, Epidermal growth factor receptor, Epidermal growth factor receptor(EGFRv)III Chimeric antigen receptor (CAR) transduced PBL)

Malignant Glioma; Glioblastoma · EGFR

#EGFR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Active
CGTLimited DatastaleNational Eye Institute (NEI)Phase 1

Higher (injection of scAAV2-P1ND4v2 1.0 X10e11vg, injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#Popular#cell-gene-therapy+3
Trials 61Status Active
CGTLimited DatastaleNational Eye Institute (NEI)Phase 1

injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low, injection of scAAV2-P1ND4v2 1.18x10e9 vg, injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),)

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 61Status Active
CGTLimited DatastaleNational Eye Institute (NEI)Phase 1

High (injection of scAAV2-P1ND4v2 2.4 X10e10vg, injection of scAAV2-P1ND4v2 2.4 X10e10vg (High))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 61Status Active
CGTLimited DatastaleNational Eye Institute (NEI)Phase 1

Med (injection of scAAV2-P1ND4v2 5.81 X10e9 vg, injection of scAAV2-P1ND4v2 5.81 X10e9 vg (Med))

Leber's Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy

#LebersHereditaryOpticNeuropathy#CGT#Phase1#Popular#cell-gene-therapy+3
Trials 61Status Active
CGTLimited DatastaleTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
CGTLimited DatastaleTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
CGTLimited DatastaleTurnstone Biologics, Corp.Phase 1

RT-01 (Oncolytic Virus Injection, Oncolytic Virus Injection(RT-01))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 60Status Active
CGTLimited DatastaleAbClonPhase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 59Status Recruiting
CGTLimited DatastaleImmunityBio, Inc.Phase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#Popular#cell-gene-therapy+3
Trials 59Status Discontinued
CGTLimited DatastaleBinhui Biopharmaceutical Co., L…Phase 1

IDOV-SAFETM (Oncolytic Virus injection, Oncolytic Virus injection(IDOV-SAFETM))

Neoplasms · Neoplasms

#Neoplasms#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 59Status Recruiting
CGTLimited DatastaleSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTAAVLimited DatastaleBayerPhase 1

AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV, AAVrh.10hFXN, serotype rh.10 adeno-associated virus, AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN)

Friedreich Ataxia; Cardiomyopathies · Friedreich Ataxia

#FriedreichAtaxia#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 58Status Recruiting
CGTLimited DatastaleCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Leukemia; Lymphoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
CGTLimited DatastaleMedigen Vaccine Biologics Corp.Phase 1

Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell, Recombinant Oncolytic HSV-2 Therapeutic Injecta, Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF))

Melanoma Stage IV · Melanoma Stage IV

#MelanomaStageIV#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTLimited DatastaleMultan Medical And Dental Colle…Phase 2

Isotretinoin (Isotretinoin)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 57Status Discontinued
CGTLimited DatastaleGilead SciencesPhase 1

Ledipasvir-Sofosbuvir (Ledipasvir-Sofosbuvir)

Chronic Hepatitis C · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 57Status Active
CGTLimited DatastaleImmunityBio, Inc.Phase 2

IL-15 Superagonist (N-803, N-803 (IL-15 Superagonist))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 57Status Discontinued
CGTLimited DatastaleImmunityBio, Inc.Phase 2

ALT-803 (ALT-803)

Melanoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Discontinued

2 / 59 pages

← PreviousNext →